Michael Ryskin
Stock Analyst at Bank of America Securities
(4.27)
# 1,414
Out of 4,974 analysts
710
Total ratings
59.2%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PAHC Phibro Animal Health | Reiterated: Sell | $35 | $37.67 | -7.09% | 16 | Aug 31, 2026 | |
| A Agilent Technologies | Maintained: Buy | $155 → $180 | $153.84 | +17.00% | 25 | Aug 27, 2026 | |
| IDXX IDEXX Laboratories | Maintained: Hold | $660 → $665 | $554.99 | +19.82% | 33 | Aug 14, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | $32 → $34 | $24.11 | +41.02% | 36 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Hold | $27 → $31 | $30.71 | +0.94% | 2 | Aug 10, 2026 | |
| TXG 10x Genomics | Maintained: Hold | n/a | $61.54 | - | 28 | Aug 7, 2026 | |
| SDGR Schrödinger | Maintained: Buy | n/a | $19.70 | - | 23 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | n/a | $25.63 | - | 9 | Aug 6, 2026 | |
| BRKR Bruker | Maintained: Buy | n/a | $57.08 | - | 26 | Aug 5, 2026 | |
| ILMN Illumina | Maintained: Sell | $140 | $215.59 | -35.06% | 48 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.03 | - | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $400 → $415 | $414.69 | +0.07% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $216.07 | +6.45% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.2 | $3.16 | +1.27% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $52 | $64.04 | -18.80% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,398.58 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $161.50 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $157.58 | - | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $170.02 | -5.89% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $335.11 | +7.43% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $18.81 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $77.34 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $261.75 | +6.97% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $265 | $242.76 | +9.16% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $337.47 | +21.49% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $630 → $650 | $622.18 | +4.47% | 30 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.4 | $1.91 | +25.65% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $16 | $18.05 | -11.36% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $291.50 | - | 19 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $128.80 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $43.11 | +13.66% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $14.58 | -24.55% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $7.68 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $8.35 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $6.96 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $8.71 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.34 | n/a | 2 | Apr 18, 2022 |
Phibro Animal Health
Aug 31, 2026
Reiterated: Sell
Price Target: $35
Current: $37.67
Upside: -7.09%
Agilent Technologies
Aug 27, 2026
Maintained: Buy
Price Target: $155 → $180
Current: $153.84
Upside: +17.00%
IDEXX Laboratories
Aug 14, 2026
Maintained: Hold
Price Target: $660 → $665
Current: $554.99
Upside: +19.82%
Elanco Animal Health
Aug 12, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $24.11
Upside: +41.02%
Alamar Biosciences
Aug 10, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $30.71
Upside: +0.94%
10x Genomics
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $61.54
Upside: -
Schrödinger
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $19.70
Upside: -
Caris Life Sciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $25.63
Upside: -
Bruker
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $57.08
Upside: -
Illumina
Aug 5, 2026
Maintained: Sell
Price Target: $140
Current: $215.59
Upside: -35.06%
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $21.03
Upside: -
Aug 4, 2026
Maintained: Hold
Price Target: $400 → $415
Current: $414.69
Upside: +0.07%
Aug 3, 2026
Maintained: Buy
Price Target: $230
Current: $216.07
Upside: +6.45%
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $3.16
Upside: +1.27%
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $64.04
Upside: -18.80%
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $1,398.58
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $161.50
Upside: -
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $157.58
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $170.02
Upside: -5.89%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $335.11
Upside: +7.43%
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $18.81
Upside: -
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $77.34
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $261.75
Upside: +6.97%
Jul 24, 2026
Reiterated: Buy
Price Target: $245 → $265
Current: $242.76
Upside: +9.16%
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $337.47
Upside: +21.49%
Jul 23, 2026
Maintained: Buy
Price Target: $630 → $650
Current: $622.18
Upside: +4.47%
Jul 15, 2026
Maintained: Sell
Price Target: $2.4
Current: $1.91
Upside: +25.65%
Jul 13, 2026
Maintained: Hold
Price Target: $11 → $16
Current: $18.05
Upside: -11.36%
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $291.50
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $128.80
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $43.11
Upside: +13.66%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $14.58
Upside: -24.55%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $7.68
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $8.35
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $6.96
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $8.71
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.34
Upside: n/a